MiR-122 also targets Krueppel-like factor 6 (KLF6), a pro-fibrogenic factor, and miR-122-deficient mice developed hepatic inflammation, fibrosis and HCC, suggesting an anti-inflammatory role of miR-122 in the liver [114]. This evidence concerns the gene KLF6 and hepatocellular carcinoma.